Biosimilars group commends FTC probe into business practices of prescription drug middleman 08-Jun-2022 By Jane Byrne The US Federal Trade Commission (FTC) announced on June 7 that it will examine pharmacy benefit managers’ role at the center of the US pharmaceutical system.